Fengchao Lang

1.0k total citations
31 papers, 714 citations indexed

About

Fengchao Lang is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Fengchao Lang has authored 31 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Fengchao Lang's work include Cytomegalovirus and herpesvirus research (10 papers), Herpesvirus Infections and Treatments (8 papers) and Viral-associated cancers and disorders (7 papers). Fengchao Lang is often cited by papers focused on Cytomegalovirus and herpesvirus research (10 papers), Herpesvirus Infections and Treatments (8 papers) and Viral-associated cancers and disorders (7 papers). Fengchao Lang collaborates with scholars based in United States, China and India. Fengchao Lang's co-authors include Chunzhang Yang, Fu-Ju Chou, Rajnish Kumar Singh, Yonggang Pei, Erle S. Robertson, Yang Liu, Kunfeng Sun, Shengwei Zhang, Jumin Zhou and Hem Chandra Jha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Virology.

In The Last Decade

Fengchao Lang

29 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengchao Lang United States 16 423 191 164 158 100 31 714
Bok Sil Hong South Korea 14 801 1.9× 386 2.0× 105 0.6× 166 1.1× 177 1.8× 28 1.2k
Guijie Guo China 21 730 1.7× 467 2.4× 142 0.9× 203 1.3× 229 2.3× 45 1.1k
Nadine Hein Australia 14 849 2.0× 115 0.6× 148 0.9× 278 1.8× 59 0.6× 36 1.1k
Eleonora Vecchio Italy 17 479 1.1× 222 1.2× 42 0.3× 110 0.7× 152 1.5× 28 719
Xianbo Huang China 15 328 0.8× 106 0.6× 71 0.4× 140 0.9× 101 1.0× 42 606
Song He China 14 561 1.3× 134 0.7× 130 0.8× 375 2.4× 65 0.7× 34 896
Sivarajan T. Chettiar United States 11 329 0.8× 120 0.6× 169 1.0× 134 0.8× 35 0.3× 15 618
Allon Canaan United States 14 383 0.9× 74 0.4× 150 0.9× 170 1.1× 202 2.0× 23 698
Anirban Ghosh India 19 411 1.0× 86 0.5× 408 2.5× 240 1.5× 233 2.3× 55 1.1k

Countries citing papers authored by Fengchao Lang

Since Specialization
Citations

This map shows the geographic impact of Fengchao Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengchao Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengchao Lang more than expected).

Fields of papers citing papers by Fengchao Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengchao Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengchao Lang. The network helps show where Fengchao Lang may publish in the future.

Co-authorship network of co-authors of Fengchao Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengchao Lang. A scholar is included among the top collaborators of Fengchao Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengchao Lang. Fengchao Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Fengchao, Karambir Kaur, Javeria Zaheer, Diego Luís Ribeiro, & Chunzhang Yang. (2025). Myt1 Kinase: An Emerging Cell-Cycle Regulator for Cancer Therapeutics. Clinical Cancer Research. 31(6). 960–964. 2 indexed citations
2.
Lang, Fengchao & Chunzhang Yang. (2025). Targeting cell cycle checkpoints for glioma therapy. Pharmacology & Therapeutics. 275. 108932–108932.
3.
4.
Lang, Fengchao, Karambir Kaur, Haiqing Fu, et al.. (2025). D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming. Nature Communications. 16(1). 1431–1431. 2 indexed citations
5.
Liu, Jiawei, et al.. (2024). Experimental study on deformation mechanism around indentation of GH4169 alloy. Journal of Alloys and Compounds. 1010. 177914–177914. 1 indexed citations
6.
Liu, Yang, Fu-Ju Chou, Fengchao Lang, et al.. (2023). Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2. Clinical Cancer Research. 29(7). 1305–1316. 23 indexed citations
7.
Lang, Fengchao, James A. Cornwell, Karambir Kaur, et al.. (2023). Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents. Neuro-Oncology. 26(6). 1083–1096. 8 indexed citations
8.
Chou, Fu-Ju, Yang Liu, Fengchao Lang, & Chunzhang Yang. (2021). D-2-Hydroxyglutarate in Glioma Biology. Cells. 10(9). 2345–2345. 48 indexed citations
9.
Lang, Fengchao, Abhishek Jha, Leah Meuter, Karel Pacák, & Chunzhang Yang. (2021). Identification of Isocitrate Dehydrogenase 2 (IDH2) Mutation in Carotid Body Paraganglioma. Frontiers in Endocrinology. 12. 731096–731096. 7 indexed citations
10.
Lang, Fengchao, Xin Li, Olga Vladimirova, et al.. (2021). Author Correction: CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Scientific Reports. 11(1). 5039–5039. 1 indexed citations
11.
Li, Xin, Yafen Yu, Fengchao Lang, et al.. (2021). Cohesin promotes HSV-1 lytic transcription by facilitating the binding of RNA Pol II on viral genes. Virology Journal. 18(1). 26–26. 9 indexed citations
12.
Lang, Fengchao, Yang Liu, Fu-Ju Chou, & Chunzhang Yang. (2021). Genotoxic therapy and resistance mechanism in gliomas. Pharmacology & Therapeutics. 228. 107922–107922. 78 indexed citations
13.
Liu, Yang, Fengchao Lang, Fu-Ju Chou, Kareem A. Zaghloul, & Chunzhang Yang. (2020). Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications. Biomedicines. 8(9). 294–294. 49 indexed citations
14.
Pei, Yonggang, Fengchao Lang, Lanlan Zhou, et al.. (2020). Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform. Communications Biology. 3(1). 267–267. 21 indexed citations
15.
Lang, Fengchao, Rajnish Kumar Singh, Yonggang Pei, et al.. (2019). EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. PLoS Pathogens. 15(6). e1007796–e1007796. 96 indexed citations
16.
Singh, Rajnish Kumar, Fengchao Lang, Yan Yuan, et al.. (2019). KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation. PLoS Pathogens. 15(9). e1008025–e1008025. 16 indexed citations
17.
Lang, Fengchao, et al.. (2018). Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis. Cancer treatment and research. 177. 81–103. 10 indexed citations
18.
Singh, Rajnish Kumar, et al.. (2018). Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia. PLoS Pathogens. 14(5). e1007062–e1007062. 49 indexed citations
19.
Lang, Fengchao, Xin Li, Olga Vladimirova, et al.. (2017). CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Scientific Reports. 7(1). 36 indexed citations
20.
Su, Yuanyuan, Hongmei Liu, Fengchao Lang, et al.. (2016). Visualizing the replicating HSV-1 virus using STED super-resolution microscopy. Virology Journal. 13(1). 65–65. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bok Sil Hong Breakdown of academic impact, for papers by Guijie Guo Breakdown of academic impact, for papers by Nadine Hein Breakdown of academic impact, for papers by Eleonora Vecchio Breakdown of academic impact, for papers by Xianbo Huang Breakdown of academic impact, for papers by Song He Breakdown of academic impact, for papers by Sivarajan T. Chettiar Breakdown of academic impact, for papers by Allon Canaan Breakdown of academic impact, for papers by Anirban Ghosh
Rankless by CCL
2026